Correlation Between Duzhe Publishing and BrightGene Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duzhe Publishing and BrightGene Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duzhe Publishing and BrightGene Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duzhe Publishing Media and BrightGene Bio Medical, you can compare the effects of market volatilities on Duzhe Publishing and BrightGene Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duzhe Publishing with a short position of BrightGene Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duzhe Publishing and BrightGene Bio.

Diversification Opportunities for Duzhe Publishing and BrightGene Bio

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Duzhe and BrightGene is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Duzhe Publishing Media and BrightGene Bio Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BrightGene Bio Medical and Duzhe Publishing is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duzhe Publishing Media are associated (or correlated) with BrightGene Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BrightGene Bio Medical has no effect on the direction of Duzhe Publishing i.e., Duzhe Publishing and BrightGene Bio go up and down completely randomly.

Pair Corralation between Duzhe Publishing and BrightGene Bio

Assuming the 90 days trading horizon Duzhe Publishing Media is expected to under-perform the BrightGene Bio. In addition to that, Duzhe Publishing is 1.43 times more volatile than BrightGene Bio Medical. It trades about -0.54 of its total potential returns per unit of risk. BrightGene Bio Medical is currently generating about -0.28 per unit of volatility. If you would invest  3,360  in BrightGene Bio Medical on October 16, 2024 and sell it today you would lose (405.00) from holding BrightGene Bio Medical or give up 12.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Duzhe Publishing Media  vs.  BrightGene Bio Medical

 Performance 
       Timeline  
Duzhe Publishing Media 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Duzhe Publishing Media are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Duzhe Publishing may actually be approaching a critical reversion point that can send shares even higher in February 2025.
BrightGene Bio Medical 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BrightGene Bio Medical are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, BrightGene Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Duzhe Publishing and BrightGene Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duzhe Publishing and BrightGene Bio

The main advantage of trading using opposite Duzhe Publishing and BrightGene Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duzhe Publishing position performs unexpectedly, BrightGene Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrightGene Bio will offset losses from the drop in BrightGene Bio's long position.
The idea behind Duzhe Publishing Media and BrightGene Bio Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
CEOs Directory
Screen CEOs from public companies around the world